Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 09 Oct 2024
Despite considerable progress in the discovery and development of new cancer drugs, there are significant disparities in both the availability and timeliness of these medicines worldwide, with poorer countries missing out, ...
Read Full NewsDupilumab significantly improves sinus opacification and disease burden in patients with allergic fungal rhinosinusitis.
Oral fecal microbiota transplant raises the amount of peanut that some highly allergic adults can tolerate, serving as proof of concept for microbiome-based food allergy therapy.
Dupilumab yields sustained benefits in terms of nasal congestion, sense of smell, and quality of life in patients with CRSwNP over 24 months in a real-world global registry.
Adults with childhood-onset systemic lupus erythematosus face a strikingly different disease trajectory than those diagnosed later in life, spending less time in the low disease activity state.
Acarizax is now the first house dust mite immunotherapy accepted by the SMC for patients with persistent allergic rhinitis.
1.
Optimizing Sequencing of BCMA-Directed Therapies in Myeloma
2.
A new therapeutic approach could help tackle radiation resistance in childhood brain tumors
3.
What Comes After Cancer?
4.
If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version
5.
Significant worldwide disparities seen in availability and timeliness of new cancer drugs
1.
Living Better With Advanced Cancer Through Supportive Care
2.
Interplay of Brown Hair, Follicular Biology, and Hair Growth Inhibitors in Melanoma Pathogenesis
3.
Unveiling the Chadwick Sign: A Revolutionary New Tool for Detecting Early Signs of Cancer
4.
Quality of Life Following Functional Hematopoietic Recovery
5.
Precision to Personalization: Expanding Genetic Testing and Counseling in Oncology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
4.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
5.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge